DEXASITE
Live / Allowed — Notice of allowance issued (as of 06 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Sept 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98170971
- Mark type
- Stylized text
- Filed
- 08 Sept 2023
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Eye drops; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of diseases or disorders of the eye; Pharmaceutical preparations for the treatment of inflammation and pain in the eye
Owner
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
Prior registrations
Prosecution history
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 01 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Feb 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 04 Nov 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Nov 2024 — FINAL REFUSAL E-MAILED
- 04 Nov 2024 — FINAL REFUSAL WRITTEN
- 25 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED